French venture capital house Omnes Capital has led an €8.4m funding round for Milan-based Newronika, a startup specialising in Deep Brain Stimulation (DBS) for the treatment of neurological diseases.
Company plans to open offices in New York and Los Angeles, and launch a new SaaS product
Bridges drew equity from its Evergreen fund, which held a final close on £50m in July 2018
Fund targets European companies operating in the consumer, industrial and healthcare services sectors
GP launched a small-cap strategy in Q3 to back companies of the size of ID Systemes